2026. [Cost-Consequence Analysis of Vedolizumab Initiation Timing Strategies in Crohn’s Disease in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways. 27, 1 (Mar. 2026). DOI:https://doi.org/10.7175/fe.v27i1.1605.